Cefuroxime prophylaxis in biliary surgery: single versus triple dose

Area of Science:

• Infectious Diseases
• Surgical Prophylaxis
• Pharmacology

Background:

• The standard prophylaxis for biliary surgery involves three doses of cephalosporins.
• Optimizing antibiotic regimens is crucial for patient outcomes and resource management.

Purpose of the Study:

• To compare the efficacy of a single dose of cefuroxime versus a standard three-dose regimen for biliary surgery prophylaxis.
• To evaluate the impact of a simplified cefuroxime regimen on infection rates and potential benefits.

Main Methods:

• A randomized study involving 100 patients undergoing biliary surgery.
• Group 1 received a single intravenous dose of cefuroxime (1.5g).
• Group 2 received the standard regimen: 1.5g IV on call, followed by 750mg IV at 8 and 16 hours post-surgery.

Main Results:

• The incidence of infection was 9% in the single-dose group and 7% in the triple-dose group.
• No significant differences were observed between groups regarding patient demographics or surgical factors.
• Both regimens demonstrated comparable efficacy in preventing surgical site infections.

Conclusions:

• A single dose of cefuroxime is as effective as the standard three-dose regimen for biliary surgery prophylaxis.
• This single-dose regimen offers advantages including reduced risk of side effects, suprainfections, and bacterial resistance.
• The simplified regimen improves convenience for nursing staff and halves the overall cost.